Celiac disease is an autoimmune disease in which the lining of the small intestine is damaged when gluten food is eaten. This disease can lead to various health problems such as miscarriage or infertility, intestinal cancer, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects.
Research and Development in Healthcare Industry
Increasing awareness about the healthcare Industry and Increase in Disposable Income among the population
Higher Consumption of Gluten-Containing Food and Ongoing Research on Celiac Disease Drug
The Players Covered in the Study are:
F. Hoffmann-La Roche (Switzerland), Johnson & Johnson (United States), Merck (United States), Pfizer (United States), ADMA Biologics (United States), Amgen (United States), Anthera Pharmaceuticals (United States), Bayer (Germany), Biogen (United States), BioLineRx (Israel) and Biotest (Germany)
List of players that can be included in the study on immediate basis are Bristol-Myers Squibb (United States), Celgene (United States), Takeda Pharmaceutical (Japan), Novartis (Switzerland), LFB Group (United States) and Kedrion Biopharma (United States).